SMA drug risdiplam successful in SUNFISH study

7th February 2020 Uncategorised 0

Risdiplam is the first potential treatment to have pivotal placebo-controlled data in a broad population of patients, including children, teenagers and adults.

More: SMA drug risdiplam successful in SUNFISH study
Source: News